Haemonetics Corp. (HAE) Tops Q2 EPS by 1c

Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.47, $0.01 better than the analyst estimate of $0.46. Revenue for the quarter came in at $227.6 million versus the consensus estimate of $229.9 million.

For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Goldman Sachs Upgrades Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) to Buy
• JD.com earnings preview: stronger profit expected, macro headwinds in focus